Therapy News and Research

RSS

Hormonal treatments reduce risk of cancer returning

Women diagnosed with breast cancer who carry a certain genetic mutation can have breast-sparing surgery but should consider hormonal treatments to reduce their risk of cancer returning.

6 Jun 2006

Novel research points to promising relief target for chronic pain

By some accounts, chronic pain affects nearly 100 million Americans from such varied causes as arthritis, sciatica, cancer, diabetes. Most forms of pain result from identifiable causes which serve the "good" purpose in warning of a real physical problem that needs attention, or rest.

6 Jun 2006

Factors influencing the route of administration for Epoetin treatment among hemodialysis patients in the U.S.

A forthcoming article to be published in the July 2006 issue of the American Journal of Kidney Diseases finds that physician decision-making for the delivery of epoetin therapy is primarily influenced by the type of ownership and financial incentives associated with dialysis centers.

6 Jun 2006

Atorvastatin may increase new blood vessel formation

Systemic sclerosis (SSc), also known as scleroderma, is an uncommon and confounding disease characterized by excessive fibrous tissue formation and vascular abnormalities.

6 Jun 2006

Gene therapy used to accelerate muscle regeneration

Researchers have successfully used gene therapy to accelerate muscle regeneration in experimental animals with muscle damage.

6 Jun 2006

New drug combo to cut cardiovascular disease

A major international study to test whether a new combination treatment that increases good "HDL" cholesterol prevents heart attacks and strokes will start to recruit patients later this year.

6 Jun 2006

Potential new treatment for diabetic nerve damage

A potentially ground-breaking treatment for nerve damage caused by diabetes has shown promising results in preclinical and early patient trials.

From The University of Manchester 6 Jun 2006

Knowledge helps prevent spread of herpes virus

A new study suggests that the risk of transmitting the virus that causes most cases of genital herpes could be cut in half by more testing and informing sexual partners of infection.

6 Jun 2006

Anger syndrome not just bouts of bad behaviour

Researchers in the United States are saying that Intermittent Explosive Disorder (IED) often known as Road Rage, may be far more common than previously thought.

6 Jun 2006

Addition of gemcitabine to standard postoperative treatment increased pancreatic cancer patients' survival by 50 percent

Adding the cancer-fighting drug gemcitabine to standard therapy after surgery significantly improves survival for patients with the most common form of pancreatic cancer, according to a new multicenter study led by a University of Maryland radiation oncologist.

6 Jun 2006

Advanced prostate cancer can be treated successfully with intermittent chemotherapy

Advanced prostate cancer can be treated successfully with intermittent chemotherapy, according to a study conducted by Oregon Health & Science University Cancer Institute scientists.

6 Jun 2006

Hydrophobic statins not associated with increased breast cancer risk

A report published in the Journal of the National Cancer Institute found that women who took statins--the widely used cholesterol lowering drugs--do not face an increased breast cancer risk as had been suggested by some previous studies.

6 Jun 2006

Cigarette smoking and high cholesterol predict different forms of peripheral artery disease

Cigarette smoking and high cholesterol predict risk for some forms of peripheral artery disease (PAD), while diabetes predicts risk for other forms of the disease, researchers reported in a rapid access issue of Circulation: Journal of the American Heart Association.

6 Jun 2006

Therapy News and Research

Hormonal treatments reduce risk of cancer returning

Novel research points to promising relief target for chronic pain

Factors influencing the route of administration for Epoetin treatment among hemodialysis patients in the U.S.

Atorvastatin may increase new blood vessel formation

Gene therapy used to accelerate muscle regeneration

New drug combo to cut cardiovascular disease

Potential new treatment for diabetic nerve damage

Knowledge helps prevent spread of herpes virus

Anger syndrome not just bouts of bad behaviour

Addition of gemcitabine to standard postoperative treatment increased pancreatic cancer patients' survival by 50 percent

Advanced prostate cancer can be treated successfully with intermittent chemotherapy

Hydrophobic statins not associated with increased breast cancer risk

Cigarette smoking and high cholesterol predict different forms of peripheral artery disease

Study confirms Gleevec's long-term benefits in treating advanced gastrointestinal stromal tumors

Study finds ways to improve detection of blood clots in the lung

FDA approves resumed marketing of Tysabri

Sunitinib therapy shows promise in children with metastatic gastrointenstinal stromal tumor

Sunitinib malate drug shows significant benefits over standard treatment for advanced kidney cancer

Trials funded by for-profit organizations more likely to report positive findings

Taxotere combined with standard chemotherapy improves survival in advanced head and neck cancers

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News